Interferon beta-1a intramuscular injection is used to reduce the number of episodes of symptoms and slow the development of disability in patients with relapsing-remitting forms (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control). Interferon beta-1a is in a class of medications called immunomodulators. It is not known how interferon beta-1a works to treat MS.
Interferon beta-1a intramuscular injection comes as a powder in vials to be mixed into a solution for injection. Interferon beta-1a intramuscular injection also comes as a solution (liquid) in prefilled injection syringes and in a prefilled automatic injection pen. This medication is injected into a muscle, usually once a week, on the same day each week. Inject interferon beta-1a intramuscular at around the same time of day on your injection days. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use interferon beta-1a exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
Interferon beta-1a controls the symptoms of MS but does not cure it. Continue to use interferon beta-1a even if you feel well. Do not stop using interferon beta-1a without talking to your doctor.
You will receive your first dose of interferon beta-1a intramuscular in your doctor's office. After that, you can inject interferon beta-1a intramuscular yourself or have a friend or relative perform the injections. Ask your doctor or pharmacist to show you or the person who will be injecting the medication how to inject it. Before you use interferon beta-1a intramuscular for the first time, you or the person who will be giving the injections should also read the manufacturer's information for the patient that comes with it. Follow the directions carefully.
Be sure you know what type of container your interferon beta 1b comes in and what other supplies, such as needles or syringes, you will need to inject your medication. If your interferon beta 1b intramuscular comes in vials, you will need to use a syringe and needle to inject your dose.
Always use a new, unopened vial, prefilled syringe and needle, or prefilled automatic injection pen for each injection. Never reuse vials, syringes, needles, or automatic injection pens. Discard used syringes, needles, and injection pens in a puncture-resistant container, kept out of reach of children. Talk to your doctor or pharmacist about how to discard the puncture-resistant container.
Always look at the medication in your vial, prefilled syringe, or automatic injection pen before you use it. If you are using a vial, the solution in the vial should be clear to slightly yellow after mixing. If you are using a prefilled syringe or automatic injection pen, the solution should be clear and colorless. If the solution is cloudy, discolored, or contains particles or if the expiration date marked on the vial, prefilled syringe, or automatic injection pen has passed, do not use that vial, prefilled syringe, or automatic injection pen.
Talk to your doctor or pharmacist about where on your body you should inject interferon beta-1a intramuscular. If you are using a syringe or prefilled syringe, you can inject interferon beta-1a intramuscular in your upper arms or thighs. If you are using a prefilled autoinjection pen, you can inject interferon beta-1a intramuscular in the outer surface of your upper thighs. Use a different spot for each injection. Do not use the same spot two times in a row. Do not inject into an area where the skin is sore, red, bruised, scarred, infected, irritated, or abnormal in any way.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (medication guide) when you begin treatment with interferon beta-1a and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website ( Web Site) to obtain the interferon beta-1a Medication Guide.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Before using interferon beta-1a,
Unless your doctor tells you otherwise, continue your normal diet.
Inject the missed dose as soon as you remember it. Do not inject interferon beta-1a two days in a row. Do not inject a double dose to make up for a missed dose. Return to your regular dosing schedule the following week. Call your doctor if you miss a dose and have questions about what to do.
Interferon beta-1a may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:
Interferon beta-1a may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online ( Web Site ) or by phone (1-800-332-1088).
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store interferon beta-1a intramuscular prefilled syringes, vials, and automatic injection pens in the refrigerator. Do not freeze interferon beta-1a, and do not expose the medication to high temperatures. If a refrigerator is not available, you can store the vials of interferon beta-1a intramuscular at room temperature, away from heat and light, for up to 30 days. After you mix interferon beta-1a powder with sterile water, store it in the refrigerator and use it within 6 hours. If a refrigerator is not available, you can store prefilled syringes and injection pens at room temperature, away from heat and light, for up to 7 days..
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website ( Web Site) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. Web Site
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at Web Site. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to interferon beta-1a.
Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
AHFS® Consumer Medication Information. © Copyright, The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
Selected Revisions: May 15, 2016.